The global hemophilia market is expanding as advances in replacement therapies, non-factor treatments, gene therapy, and specialized care improve the management of this rare genetic bleeding disorder. Increasing diagnosis, growing awareness, and the development of therapies that can reduce treatment burden are supporting market expansion. The shift toward longer-acting and innovative treatments...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)